Definium Therapeutics (DFTX) Debt Ratio (2023 - 2026)

Definium Therapeutics (DFTX) has 4 years of Debt Ratio data on file, last reported at 0.1 in Q1 2026.

• Quarterly Debt Ratio rose 26.95% year-over-year to 0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.1 (up 26.95% YoY) and the FY2025 annual result came in at 0.09, up 27.48% from the prior year.
• Debt Ratio climbed to 0.1 in Q1 2026 per DFTX's latest filing, from 0.09 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.17 in Q3 2025 and bottomed at 0.05 in Q1 2024.
• The 4-year median for Debt Ratio is 0.09 (2025), against an average of 0.1.
• The widest annual swing landed in 2024, when Debt Ratio plunged 36.25%; it then surged 124.21% in 2025.
• Tracing DFTX's Debt Ratio over 4 years: stood at 0.11 in 2023, then tumbled by 36.25% to 0.07 in 2024, then advanced by 27.48% to 0.09 in 2025, then advanced by 10.19% to 0.1 in 2026.
• Per Business Quant, the three latest DFTX Debt Ratio figures stand at 0.1 (Q1 2026), 0.09 (Q4 2025), and 0.17 (Q3 2025).

Peer Comparison